from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3040c/-

LFCtreatmentdescriptionclass of inhibitor

-1.550

Amikacinug/mL Amikacintranslation

-1.148

Cap5-10ug/mL Capreomycintranslation

-1.926

Rox10-50 ug/mL Roxithromycintranslation

-0.328

SM2-5 ug/mL Streptomycintranslation

-2.455

Tet5-10 ug/mL Tetracyclinetranslation

-0.437

Rif0.2-5ug/mL Rifampicintranscription

-0.359

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.490

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.444

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.233

CPZ10-50 ug/mL Chlorpromazinerespiration

0.410

Clofazimine10-13 ug/mL Clofaziminerespiration

0.694

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.895

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.188

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.280

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.869

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.749

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.256

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.952

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.097

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.273

KCN5-20 ug/mL Potassium cyaniderespiration

-0.125

NaN30.2-2 mM Sodium aziderespiration

0.458

Nigericin50 uM Nigericinrespiration

-1.093

TRC10-150 ug/mL Triclosanrespiration

-1.029

TRZ10-25 ug/mL Thioridazinerespiration

-1.512

Valinomycin0.5-10 uM Valinomycinrespiration

0.210

ZnSO42 mM ZnSO4respiration

1.099

menadione6-10 ug/mL Menadionerespiration

0.152

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.166

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.249

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.535

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.665

NRP_1Non-replicating persistence stage 1dosRassociated

0.608

Amp0.2mg/mL AmpicillincellWall

0.481

Cephalexin20-100 ug/mL CephalexincellWall

-0.343

Cerulenin0.32-5 ug/mL CerulenincellWall

0.448

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.042

EMB10-20 ug/mL EthambutolcellWall

-0.249

Eta12-40 ug/mL EthionamidecellWall

-0.475

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.355

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.303

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.646

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.607

BZA0.12 mg/mL BenzamidearomaticAmides

0.258

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.316

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.020

H2O24 mM hydrogen peroxideDNAdamaging

-0.777

Levo10 ug/mL LevofloxacinDNAdamaging

0.325

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.525

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.598

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.197

UVUV-irradiationDNAdamaging

0.506

ARP41-4 ug/mL Antitubercular compound ARP4?

0.475

Antimycin12.5-50 ug/mL Antimycin A?

0.462

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.105

PA_110-50 ug/mL Antitubercular compound PA-1?

0.020

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.891

PA8240.2-2 ug/mL PA-824?

-0.489

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.033

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.345

Verapamil50 uM Verapamil?

0.577

mercaptoethanol2 mM 2-Mercaptoethanol?

0.950

methoxatin10-20 ug/mL Methoxatin?